news_6

MEI Pharma and Kyowa Kirin Announce Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib as a Single Agent in Patients with Relapsed or Refractory Follicular Lymphoma

– Zandelisib Demonstrated 70.3% Objective Response Rate; 35.2% Achieved Complete Response – – 9.9% of Patients Discontinued Therapy Due to...

news_6

Japanese brands Yakult, Nippon Rent-A-Car, Sukiya, Natural Aqua Gel Cure and Family Mart among the winners as the 2021 World Branding Awards go Virtual

LONDON--(BUSINESS WIRE)--#worldbranding--The fourteenth edition of the World Branding Awards saw 500+ brands from more than 60 countries named as the...

news_6

Merck’s KEYTRUDA® (pembrolizumab) Approved in Japan in Combination With Chemotherapy for First-Line Treatment of Patients With Radically Unresectable, Advanced or Recurrent Esophageal Carcinoma

First Anti-PD-1/L1-Based Regimen Approved in Japan for First-Line Treatment of Advanced Esophageal Cancer KEYTRUDA Is Now Approved for 16 Indications...

news_6

BreadTalk, Food Republic, Toast Box, Raffles Medical, Axe Brand, Delfi, and COURTS among the winners as the 2021 World Branding Awards go Virtual

LONDON--(BUSINESS WIRE)--#worldbranding--The fourteenth edition of the World Branding Awards saw over 500 brands from more than 60 countries named as...

news_6

The “Principal Hong Kong Retirement Health Index” findings show A Happy & Healthy Retirement Life driven more by Financial Literacy – not just wealth

HONG KONG SAR - Media OutReach - 30 November 2021 - The "Principal Hong Kong Retirement Health Index 2021" survey1 (Principal HK RHI)...